Jianhua Rao

2.6k total citations · 1 hit paper
68 papers, 1.8k citations indexed

About

Jianhua Rao is a scholar working on Molecular Biology, Surgery and Hepatology. According to data from OpenAlex, Jianhua Rao has authored 68 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 21 papers in Surgery and 18 papers in Hepatology. Recurrent topics in Jianhua Rao's work include Organ Transplantation Techniques and Outcomes (13 papers), Liver Disease and Transplantation (11 papers) and Liver physiology and pathology (7 papers). Jianhua Rao is often cited by papers focused on Organ Transplantation Techniques and Outcomes (13 papers), Liver Disease and Transplantation (11 papers) and Liver physiology and pathology (7 papers). Jianhua Rao collaborates with scholars based in China, United States and South Korea. Jianhua Rao's co-authors include Xuehao Wang, Ling Lü, Feng Cheng, Yuan Zhai, Xiongxiong Pan, Ling Lu, Ling Lü, Shikun Yang, Shi Yue and Ronald W. Busuttil and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and PLoS ONE.

In The Last Decade

Jianhua Rao

65 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2

2022 152 citations Jianhua Rao, Hao Wang et al. Gut profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jianhua Rao China	25	807	447	392	342	323	68	1.8k
Shi Yue China	25	818 1.0×	384 0.9×	376 1.0×	282 0.8×	239 0.7×	37	1.6k
Xue‐Yong Zhu China	25	710 0.9×	296 0.7×	429 1.1×	166 0.5×	227 0.7×	36	1.4k
Xiongxiong Pan China	21	726 0.9×	429 1.0×	263 0.7×	230 0.7×	114 0.4×	32	1.5k
Adrien Guillot Germany	20	491 0.6×	340 0.8×	919 2.3×	259 0.8×	150 0.5×	52	1.7k
Salvatore Sutti Italy	24	404 0.5×	286 0.6×	1.1k 2.9×	193 0.6×	230 0.7×	51	1.7k
Ryan G. Holzer United States	8	786 1.0×	566 1.3×	717 1.8×	154 0.5×	169 0.5×	10	2.2k
Aijuan Qu China	32	1.3k 1.6×	270 0.6×	662 1.7×	300 0.9×	161 0.5×	66	2.9k
Hiroshi Uchinami Japan	20	875 1.1×	250 0.6×	974 2.5×	709 2.1×	228 0.7×	48	2.6k
Jianjun Zhu China	21	1.2k 1.5×	282 0.6×	251 0.6×	143 0.4×	150 0.5×	59	1.8k

Countries citing papers authored by Jianhua Rao

Since Specialization

Citations

This map shows the geographic impact of Jianhua Rao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianhua Rao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianhua Rao more than expected).

Fields of papers citing papers by Jianhua Rao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianhua Rao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianhua Rao. The network helps show where Jianhua Rao may publish in the future.

Co-authorship network of co-authors of Jianhua Rao

This figure shows the co-authorship network connecting the top 25 collaborators of Jianhua Rao. A scholar is included among the top collaborators of Jianhua Rao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianhua Rao. Jianhua Rao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rao, Jianhua, Tao Wang, Jing Huang, et al.. (2025). NEO-ERA-01: A multi-center, single-arm, phase II study with neoadjuvant therapy of HAIC (GEMOX) combined with adebrelimab and lenvatinib for resectable intrahepatic cholangiocarcinoma with high-risk recurrence factors.. Journal of Clinical Oncology. 43(16_suppl).

Yang, Yun, Li Ma, Jianhua Rao, et al.. (2025). Ceritinib–ibuprofen synergistic hepatotoxicity: Insights from real-world data and liver organoid models. Toxicology. 519. 154321–154321.

Rao, Jianhua, Chao Song, Yangyang Hao, et al.. (2024). Leveraging Patient-Derived Organoids for Personalized Liver Cancer Treatment. International Journal of Biological Sciences. 20(13). 5363–5374. 6 indexed citations

Rao, Jianhua, Zeng Wang, Fei Yu, et al.. (2024). XBP1 Facilitating NF-κB-p65 Nuclear Translocation Promotes Macrophage-Originated Sterile Inflammation Via Regulating MT2 Transcription in the Ischemia/Reperfusion Liver. Cellular and Molecular Gastroenterology and Hepatology. 18(6). 101402–101402. 1 indexed citations

Rao, Jianhua, Hao Wang, Ming Ni, et al.. (2022). FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2. Gut. 71(12). 2539–2550. 152 indexed citations breakdown →

Chen, Xiaofeng, Wei Li, Xiaofeng Wu, et al.. (2022). Safety and Efficacy of Sintilimab and Anlotinib as First Line Treatment for Advanced Hepatocellular Carcinoma (KEEP-G04): A Single-Arm Phase 2 Study. Frontiers in Oncology. 12. 909035–909035. 32 indexed citations

Yang, Wenjie, Yong Ni, Shikun Yang, et al.. (2021). The oncogene Mct-1 promotes progression of hepatocellular carcinoma via enhancement of Yap-mediated cell proliferation. Cell Death Discovery. 7(1). 57–57. 1 indexed citations

Wu, Chen, et al.. (2021). Analysis of the efficacy and prognostic factors of PD-1 inhibitors in advanced gallbladder cancer. Annals of Translational Medicine. 9(20). 1568–1568. 9 indexed citations

Wang, Peng, Ming Ni, Yizhu Tian, et al.. (2021). Myeloid Nrf2 deficiency aggravates non-alcoholic steatohepatitis progression by regulating YAP-mediated NLRP3 inflammasome signaling. iScience. 24(5). 102427–102427. 26 indexed citations

10.

Yang, Wenjie, Shikun Yang, Feng Zhang, et al.. (2020). Influence of the Hippo-YAP signalling pathway on tumor associated macrophages (TAMs) and its implications on cancer immunosuppressive microenvironment. Annals of Translational Medicine. 8(6). 399–399. 58 indexed citations

11.

Zhou, Haoming, Feng Zhan, Hui Zhang, et al.. (2019). The proportion of CD19+CD24hiCD27+ regulatory B cells predicts the occurrence of acute allograft rejection in liver transplantation. Annals of Translational Medicine. 7(18). 465–465. 16 indexed citations

12.

Rao, Jianhua, Feng Zhang, Lu Hao, et al.. (2017). Effects of multimodal fast-track surgery on liver transplantation outcomes. Hepatobiliary & pancreatic diseases international. 16(4). 364–369. 24 indexed citations

13.

Zhou, Bo, Ye Fan, Jianhua Rao, et al.. (2015). Matrix metalloproteinases-9 deficiency impairs liver regeneration through epidermal growth factor receptor signaling in partial hepatectomy mice. Journal of Surgical Research. 197(1). 201–209. 12 indexed citations

14.

Rao, Jianhua, Haoming Zhou, Guoqiang Li, et al.. (2014). Remain recipient partial liver during liver transplant after Hassab. Journal of Surgical Research. 189(2). 321–325. 3 indexed citations

15.

Rao, Jianhua, Jianjie Qin, Xiaofeng Qian, et al.. (2013). Lipopolysaccharide Preconditioning Protects Hepatocytes from Ischemia/Reperfusion Injury (IRI) through Inhibiting ATF4-CHOP Pathway in Mice. PLoS ONE. 8(6). e65568–e65568. 47 indexed citations

16.

Rao, Jianhua, Min Feng, Xiaofeng Qian, et al.. (2013). Liver transplantation treating the patient with hepatic failure associated with sorafenib treatment: report of a case.. PubMed. 60(126). 1317–9. 4 indexed citations

17.

Xia, Yongxiang, Jianhua Rao, Aihua Yao, et al.. (2012). Lithium exacerbates hepatic ischemia/reperfusion injury by inhibiting GSK-3β/NF-κB-mediated protective signaling in mice. European Journal of Pharmacology. 697(1-3). 117–125. 28 indexed citations

18.

Lu, Ling, et al.. (2010). Rapamycin Promotes the Expansion of CD4+ Foxp3+ Regulatory T Cells After Liver Transplantation. Transplantation Proceedings. 42(5). 1755–1757. 18 indexed citations

19.

Lu, Ling, Guoqiang Li, Jianhua Rao, et al.. (2009). In vitro induced CD4+CD25+Foxp3+ Tregs attenuate hepatic ischemia–reperfusion injury. International Immunopharmacology. 9(5). 549–552. 39 indexed citations

20.

Studzinski, George P., et al.. (1996). Transition to tetraploidy in 1,25-dihydroxyvitamin D3-resistant HL60 cells is preceded by reduced growth factor dependence and constitutive up-regulation of Sp1 and AP-1 transcription factors.. PubMed. 56(23). 5513–21. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact